Wilkie A. WIlson

The Novel {micro}-Opioid Receptor Antagonist, [N-Allyl-Dmt1]Endomorphin-2, Attenuates the Enhancement of GABAergic Neurotransmission by Ethanol (2009)

Li, Qiang, Okada, Yoshio, Marczak, Ewa, Wilson, Wilkie A., Lazarus, Lawrence H., Swartzwelder, H. S.

Aims: We investigated the effects of [N-allyl-Dmt1]endomorphin-2 (TL-319), a novel and highly potent μ-opioid receptor antagonist, on ethanol (EtOH)-induced enhancement of GABAA receptor-mediated...

Neuronal Degeneration in the Cingulate Gyrus: NMDA Antagonists and Anticholinesterases (1998)

WIlson, Wilkie A.

The goal of this study is to understand the interact ion between drugs that are antagonists at the NMDA receptor subtype of glutamate receptors and drugs that are anticholinesterases. Previous...

Neuronal Degeneration in the Cingulated Gyrus: NMDC Antagonists and Anticholinesterases (1998)

Wilson, Wilkie A., Jones, Katherine, Li, Qiang

The key objective of these studies is to determine the neurotoxic risk of combining acetylcholinesterase inhibitors (AChEIs) and N-methyl-D-aspartate (NMDA) receptor blockers. In this year of study...

Neuronal Degeneration in the Cingulate Gyrus: NMDA Antagonists and Anticholinesterases (1998)

Wilson, Wilkie A.

The primary objective of these studies was to determine the neurotoxic risks of combining acetyloholinesterase inhibitors (AChEIs) with N-methyl-D-aspartate (NMDA) receptor antagonists. There is...